MedVellum
MedVellum
Back to Library
Orthopaedics
Paediatrics
Genetics

Osteogenesis Imperfecta

High EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Non-Accidental Injury (Rule out - different fracture patterns)
  • Basilar Invagination
Overview

Osteogenesis Imperfecta

1. Clinical Overview

Summary

Osteogenesis Imperfecta (OI) is a genetic disorder of Type I collagen synthesis causing fragile bones, susceptibility to fractures, and other connective tissue abnormalities. Severity ranges from mild (Type I) to lethal perinatal (Type II). Treatment aims to reduce fractures and improve quality of life.

Key Facts

AspectDetail
CauseMutations in COL1A1/COL1A2 (Type I collagen genes)
InheritanceMostly autosomal dominant
Key FeatureFragile bones - fractures from minimal trauma
Classic SignsBlue sclerae, dentinogenesis imperfecta, hearing loss
Medical TreatmentBisphosphonates (increase bone density)

Clinical Pearls

  • Blue sclerae: Thin sclera allows choroidal veins to show through
  • NAI differential: OI fractures occur with minimal trauma; corner fractures and rib fractures in OI are LESS common than in NAI
  • Wormian bones: Multiple irregular bones at skull sutures - characteristic
  • Type I = Mildest: Most common form, fractures decrease after puberty

2. Epidemiology

Incidence

TypeIncidence
All types1 in 10,000-20,000 births
Type IMost common (~50%)
Type II~10% (lethal)

Genetics

TypeInheritanceNotes
IADMild
IIAD (new mutation)Lethal perinatal
IIIAD (or AR)Severe, progressive
IVADModerate

3. Pathophysiology

Collagen Defect

COL1A1/COL1A2 Gene Mutation
              ↓
Abnormal Type I Collagen Production
              ↓
Defective Bone, Skin, Dentin, Sclera, Ligaments
              ↓
FRAGILE BONES + OTHER CONNECTIVE TISSUE ABNORMALITIES

Type I Collagen Distribution

TissueManifestation
BoneFractures, deformity
ScleraBlue appearance
DentinDentinogenesis imperfecta
Inner earHearing loss (otosclerosis-like)
SkinThin, easily bruised
LigamentsHypermobility

4. Clinical Presentation

Sillence Classification

TypeSeverityFeatures
IMildBlue sclerae, fractures in childhood, normal/near-normal stature
IILethalMultiple intrauterine fractures, perinatal death
IIISevereProgressive deformity, short stature, grey sclerae
IVModerateNormal sclerae, mild-moderate deformity

Clinical Features

FeatureDescription
FracturesFrom minimal trauma, often before walking
Blue scleraeType I especially
Dentinogenesis imperfectaOpalescent, discoloured teeth
Hearing lossConductive or mixed, adult onset
Wormian bonesExtra skull bone islands
Short statureType III especially
HypermobilityJoint laxity
Triangular facies
Barrel chest

5. Clinical Examination

Systematic Assessment

SystemFindings
ScleraeBlue (Type I), grey/white (other types)
TeethDiscoloured, translucent (DI)
LimbsDeformity, shortening, bowing
HeightShort stature (especially Type III)
JointsHypermobility
HearingMay be reduced
SpineKyphoscoliosis

Distinguish from NAI

FeatureOINAI
HistoryMinimal traumaInconsistent history
Fracture typesLong bones, mostlyRib, metaphyseal corner
Associated featuresBlue sclerae, DI, family hxBruising, other injuries
Bone densityReducedNormal

6. Investigations

Diagnostic Tests

TestFinding
X-raysFractures, osteopenia, Wormian bones
DEXAReduced bone mineral density
Genetic testingCOL1A1/COL1A2 mutations (confirmatory)
Collagen analysisSkin fibroblast biopsy (historical)

X-ray Features

FindingDescription
OsteopeniaGeneralised
Wormian bonesSkull
Thin corticesLong bones
FracturesVarious healing stages
BowingLong bone deformity

7. Management

Medical Treatment

DrugDetails
BisphosphonatesIV Pamidronate or Zoledronate cycles
MechanismReduce osteoclast activity, increase bone density
BenefitsFewer fractures, less pain, improved mobility
MonitoringDEXA, vertebral imaging

Surgical Treatment

ProcedureIndication
Intramedullary roddingCorrect and stabilise bowing deformities
Telescoping rodsFassier-Duval - grow with the child
Spinal surgeryScoliosis correction

Multidisciplinary Care

SpecialistRole
OrthopaedicsFracture management, surgery
GeneticsDiagnosis, counselling
PhysiotherapyMobility, strengthening
AudiologyHearing assessment
DentistryDentinogenesis imperfecta
EndocrinologyBone health optimisation

Adjuncts

InterventionDetails
Vitamin DEnsure sufficiency
CalciumAdequate intake
PhysiotherapyLow-impact exercise, hydrotherapy
Mobility aidsWheelchairs, walkers as needed

8. Complications
ComplicationNotes
Recurrent fracturesMain morbidity
Progressive deformityBowing, short stature
ScoliosisMay be severe
Basilar invaginationCervical spine - serious
Hearing lossRequires monitoring
CardiopulmonaryRestrictive lung disease from chest deformity

9. Prognosis & Outcomes
TypePrognosis
Type INormal lifespan, fractures decrease after puberty
Type IILethal perinatally
Type IIISignificantly reduced life expectancy, wheelchair-dependent
Type IVNear-normal lifespan with treatment

10. Evidence & Guidelines
OrganisationKey Points
OI FoundationPatient resources
Brittle Bone SocietyUK charity, support
ISCDDEXA guidelines in children

11. Patient / Layperson Explanation

What is OI? Osteogenesis Imperfecta (OI), often called "brittle bone disease," is a genetic condition that makes bones break very easily. It happens because of a problem with the protein (collagen) that gives bones their strength.

What are the signs?

  • Bones that break easily, sometimes from very minor bumps
  • Blue or grey colour to the whites of the eyes
  • Dental problems
  • Hearing loss (in some cases)
  • Being shorter than average (in some types)

How is it treated?

  • Medications: Bisphosphonates (given as a drip) help strengthen bones
  • Surgery: Rods inside the bones to straighten and strengthen them
  • Physiotherapy: Keeping muscles strong and joints mobile
  • Support: Wheelchairs, walking aids when needed

What's the outlook? This varies depending on the type. Many children with milder OI grow up to live normal lives. With modern treatments, even those with more severe types are doing better than ever before.

Is it my fault? No - OI is usually a random genetic change. It's not caused by anything during pregnancy.


12. References
  1. Sillence DO, et al. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979.
  2. Forlino A, Marini JC. OI. Lancet. 2016.
  3. Brittle Bone Society. www.brittlebone.org
  4. OI Foundation. www.oif.org

Last updated: 2025-12-22

At a Glance

EvidenceHigh
Last Updated2025-12-22

Red Flags

  • Non-Accidental Injury (Rule out - different fracture patterns)
  • Basilar Invagination

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines